US Stock MarketDetailed Quotes

MGRX Mangoceuticals

Watchlist
  • 0.515
  • +0.262+103.68%
Close May 21 16:00 ET
  • 0.630
  • +0.115+22.30%
Post 19:59 ET
12.79MMarket Cap-1348P/E (TTM)

Mangoceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.38%-1.78M
-9,570.06%-1.81M
-1.35M
-3,607.53%-649.56K
-600.35K
-77.91K
Net income from continuing operations
7.55%-2.37M
-361.07%-9.21M
-281.21%-2.57M
-84.50%-1.8M
-593.21%-2.28M
-12,966.41%-2.56M
---2M
-3,705.75%-673.66K
---975.32K
---329.49K
Operating gains losses
----
----
----
----
----
----
---151.82K
----
----
----
Depreciation and amortization
2.33%6.22K
544.29%24.89K
62.85%6.29K
--6.29K
--6.22K
--6.08K
--3.86K
--3.86K
--0
--0
Other non cash items
-40.65%416.5K
178.88%1.52M
591.99%358.9K
-68.28%84.75K
67.16%378.77K
78,838.13%701.76K
--546.54K
28,554.70%51.87K
--267.2K
--226.58K
Change In working capital
4,789.18%915.8K
120.00%41.51K
35.98%76.04K
-11.48%-69.17K
116.72%54.18K
---19.53K
--18.87K
--55.92K
---62.05K
--25K
-Change in receivables
----
131.55%54.98K
----
----
----
----
---174.24K
----
----
----
-Change in inventory
--4.05K
---18.5K
--3.08K
--1.91K
---23.49K
--0
--0
--0
--0
----
-Change in prepaid assets
104.62%902
-71.53%-49.21K
159.40%23.43K
16.16%-31.62K
---21.49K
---19.53K
---28.69K
--9.03K
---37.72K
--0
-Change in payables and accrued expense
--911.79K
204.92%110.97K
40.26%50.1K
-60.59%-39.07K
299.75%99.94K
--0
--36.39K
--35.72K
---24.33K
--25K
-Change in other current assets
--14.47K
----
----
--13.73K
--27.08K
--0
----
----
--0
--0
-Change in other current liabilities
---15.41K
-130.60%-56.73K
-107.95%-14.75K
---14.12K
---27.86K
--0
--185.41K
--185.41K
--0
--0
Cash from discontinued investing activities
Operating cash flow
45.19%-991.13K
-419.66%-7M
-161.37%-1.7M
-184.96%-1.71M
-2,185.67%-1.78M
-9,564.90%-1.81M
---1.35M
-3,607.53%-649.56K
---600.35K
---77.9K
Investing cash flow
Cash flow from continuing investing activities
0
91.84%-3.52K
0
0
0
-3.52K
-43.1K
-40.57K
-2.53K
0
Net PPE purchase and sale
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
---2.53K
--0
Cash from discontinued investing activities
Investing cash flow
--0
91.84%-3.52K
--0
--0
--0
---3.52K
---43.1K
---40.57K
---2.53K
--0
Financing cash flow
Cash flow from continuing financing activities
-94.65%267.5K
244.26%7.06M
140.24%1.2M
0
3,337.79%857.04K
9,900.00%5M
2.05M
1,146.57%499.5K
1.48M
24.93K
Net issuance payments of debt
--87.5K
-435.39%-167.46K
--0
--0
-771.72%-167.46K
--0
--49.93K
--0
---25K
--24.93K
Net common stock issuance
-96.40%180K
210.00%6.2M
140.24%1.2M
--0
--0
--5M
--2M
62,337.50%499.5K
--1.5M
--0
Proceeds from stock option exercised by employees
----
--1.02M
--0
--0
----
----
--0
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
-94.65%267.5K
244.26%7.06M
140.24%1.2M
--0
3,337.79%857.04K
9,900.00%5M
--2.05M
1,146.57%499.5K
--1.48M
--24.93K
Net cash flow
Beginning cash position
8.22%739.01K
2,928.20%682.86K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
2,928.20%682.86K
--22.55K
--873.49K
--868
--53.84K
Current changes in cash
-122.70%-723.63K
-91.50%56.15K
-161.10%-497.74K
-296.05%-1.71M
-1,643.46%-923.54K
10,089.13%3.19M
--660.31K
-945.37%-190.63K
--872.62K
---52.97K
Effect of exchange rate changes
---70
----
----
----
----
--0
----
----
----
----
End cash Position
-99.60%15.31K
8.22%739.01K
8.22%739.01K
41.59%1.24M
339,473.16%2.95M
7,089.89%3.87M
--682.86K
2,928.20%682.86K
--873.49K
--868
Free cash flow
45.30%-991.13K
-403.80%-7M
-146.00%-1.7M
-183.76%-1.71M
-2,185.67%-1.78M
-9,583.70%-1.81M
---1.39M
-3,839.10%-690.13K
---602.88K
---77.9K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.38%-1.78M-9,570.06%-1.81M-1.35M-3,607.53%-649.56K-600.35K-77.91K
Net income from continuing operations 7.55%-2.37M-361.07%-9.21M-281.21%-2.57M-84.50%-1.8M-593.21%-2.28M-12,966.41%-2.56M---2M-3,705.75%-673.66K---975.32K---329.49K
Operating gains losses ---------------------------151.82K------------
Depreciation and amortization 2.33%6.22K544.29%24.89K62.85%6.29K--6.29K--6.22K--6.08K--3.86K--3.86K--0--0
Other non cash items -40.65%416.5K178.88%1.52M591.99%358.9K-68.28%84.75K67.16%378.77K78,838.13%701.76K--546.54K28,554.70%51.87K--267.2K--226.58K
Change In working capital 4,789.18%915.8K120.00%41.51K35.98%76.04K-11.48%-69.17K116.72%54.18K---19.53K--18.87K--55.92K---62.05K--25K
-Change in receivables ----131.55%54.98K-------------------174.24K------------
-Change in inventory --4.05K---18.5K--3.08K--1.91K---23.49K--0--0--0--0----
-Change in prepaid assets 104.62%902-71.53%-49.21K159.40%23.43K16.16%-31.62K---21.49K---19.53K---28.69K--9.03K---37.72K--0
-Change in payables and accrued expense --911.79K204.92%110.97K40.26%50.1K-60.59%-39.07K299.75%99.94K--0--36.39K--35.72K---24.33K--25K
-Change in other current assets --14.47K----------13.73K--27.08K--0----------0--0
-Change in other current liabilities ---15.41K-130.60%-56.73K-107.95%-14.75K---14.12K---27.86K--0--185.41K--185.41K--0--0
Cash from discontinued investing activities
Operating cash flow 45.19%-991.13K-419.66%-7M-161.37%-1.7M-184.96%-1.71M-2,185.67%-1.78M-9,564.90%-1.81M---1.35M-3,607.53%-649.56K---600.35K---77.9K
Investing cash flow
Cash flow from continuing investing activities 091.84%-3.52K000-3.52K-43.1K-40.57K-2.53K0
Net PPE purchase and sale --091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K---2.53K--0
Cash from discontinued investing activities
Investing cash flow --091.84%-3.52K--0--0--0---3.52K---43.1K---40.57K---2.53K--0
Financing cash flow
Cash flow from continuing financing activities -94.65%267.5K244.26%7.06M140.24%1.2M03,337.79%857.04K9,900.00%5M2.05M1,146.57%499.5K1.48M24.93K
Net issuance payments of debt --87.5K-435.39%-167.46K--0--0-771.72%-167.46K--0--49.93K--0---25K--24.93K
Net common stock issuance -96.40%180K210.00%6.2M140.24%1.2M--0--0--5M--2M62,337.50%499.5K--1.5M--0
Proceeds from stock option exercised by employees ------1.02M--0--0----------0--0--0----
Cash from discontinued financing activities
Financing cash flow -94.65%267.5K244.26%7.06M140.24%1.2M--03,337.79%857.04K9,900.00%5M--2.05M1,146.57%499.5K--1.48M--24.93K
Net cash flow
Beginning cash position 8.22%739.01K2,928.20%682.86K41.59%1.24M339,473.16%2.95M7,089.89%3.87M2,928.20%682.86K--22.55K--873.49K--868--53.84K
Current changes in cash -122.70%-723.63K-91.50%56.15K-161.10%-497.74K-296.05%-1.71M-1,643.46%-923.54K10,089.13%3.19M--660.31K-945.37%-190.63K--872.62K---52.97K
Effect of exchange rate changes ---70------------------0----------------
End cash Position -99.60%15.31K8.22%739.01K8.22%739.01K41.59%1.24M339,473.16%2.95M7,089.89%3.87M--682.86K2,928.20%682.86K--873.49K--868
Free cash flow 45.30%-991.13K-403.80%-7M-146.00%-1.7M-183.76%-1.71M-2,185.67%-1.78M-9,583.70%-1.81M---1.39M-3,839.10%-690.13K---602.88K---77.9K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg